| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.095 | 0.009 |